Orchard Therapeutics PLC ORTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:58 AM EDT
0.4827quote price arrow down-0.0173 (-3.46%)
Volume
27,822
52 week range
0.41 - 2.23
Loading...
  • Open0.48
  • Day High0.4979
  • Day Low0.47
  • Prev Close0.50
  • 52 Week High2.23
  • 52 Week High Date10/18/21
  • 52 Week Low0.41
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap61.04M
  • Shares Out126.46M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-62.48

KEY STATS

  • Open0.48
  • Day High0.4979
  • Day Low0.47
  • Prev Close0.50
  • 52 Week High2.23
  • 52 Week High Date10/18/21
  • 52 Week Low0.41
  • 52 Week Low Date05/12/22
  • Market Cap61.04M
  • Shares Out126.46M
  • 10 Day Average Volume0.68M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • YTD % Change-62.48

RATIOS/PROFITABILITY

  • EPS (TTM)-1.32
  • P/E (TTM)-0.37
  • Fwd P/E (NTM)-0.62
  • EBITDA (TTM)-136.673M
  • ROE (TTM)-81.82%
  • Revenue (TTM)11.57M
  • Gross Margin (TTM)74.76%
  • Net Margin (TTM)-1,452.45%
  • Debt To Equity (MRQ)22.59%

EVENTS

  • Earnings Date11/04/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Orchard Therapeutics PLC

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Orchard Therapeutics plc is a gene therapy company. The Company is engaged in development, manufacturing and commercialization of gene and cell therapies to provide curative therapies to patients suffering from a range of diseases. The Company's portfolio includes a commercial-stage product and research and development-stage product candidates. It is focused on severe neurometabolic diseases and early research programs in rare primary immune deficiencies, including OTL-103...
Address
245 Hammersmith Road, 3Rd Floor
London
W6 8PW
United Kingdom

Top Peers

SYMBOLLASTCHG%CHG
CRIS
Curis Inc
0.7155+0.0155+2.21%
EYEN
Eyenovia Inc
1.94-0.02-1.02%
HOOK
HOOKIPA Pharma Inc
1.39+0.05+3.72%
SPRO
Spero Therapeutics Inc
2.08+0.08+3.75%
TCRX
TScan Therapeutics Inc
3.05UNCHUNCH